Hampton Gillespie

1.2k total citations
13 papers, 868 citations indexed

About

Hampton Gillespie is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Hampton Gillespie has authored 13 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Clinical Psychology. Recurrent topics in Hampton Gillespie's work include Cannabis and Cannabinoid Research (10 papers), Forensic Toxicology and Drug Analysis (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Hampton Gillespie is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Forensic Toxicology and Drug Analysis (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Hampton Gillespie collaborates with scholars based in United States and Sweden. Hampton Gillespie's co-authors include Leo E. Hollister, Stig Agurell, Jan‐Erik Lindgren, Nizar A. Mullani, Nora D. Volkow, Agneta Ohlsson, Karen Johnson, Gene‐Jack Wang, A. Wahlén and Marija Ivanović and has published in prestigious journals such as Life Sciences, Clinical Pharmacology & Therapeutics and Drug and Alcohol Dependence.

In The Last Decade

Hampton Gillespie

13 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hampton Gillespie United States 11 558 366 160 129 127 13 868
Hollister Le United States 15 491 0.9× 453 1.2× 148 0.9× 97 0.8× 84 0.7× 67 1.1k
J D Sapira United States 7 242 0.4× 459 1.3× 179 1.1× 142 1.1× 118 0.9× 14 986
Itiro Shirakawa Brazil 12 836 1.5× 428 1.2× 205 1.3× 234 1.8× 83 0.7× 24 1.2k
R. T. Jones United States 13 271 0.5× 279 0.8× 115 0.7× 94 0.7× 249 2.0× 22 887
Monique C. Braude United States 20 583 1.0× 526 1.4× 77 0.5× 49 0.4× 117 0.9× 42 1.0k
Lineke Zuurman Netherlands 14 762 1.4× 471 1.3× 233 1.5× 116 0.9× 140 1.1× 22 1.1k
Susan J. Boyd United States 15 400 0.7× 343 0.9× 135 0.8× 154 1.2× 112 0.9× 21 968
William Notcutt United Kingdom 14 1.4k 2.5× 504 1.4× 290 1.8× 136 1.1× 132 1.0× 26 1.8k
Franziska Pahlisch Germany 8 802 1.4× 352 1.0× 183 1.1× 93 0.7× 67 0.5× 10 906
Heather House United Kingdom 7 868 1.6× 269 0.7× 168 1.1× 99 0.8× 126 1.0× 9 1.1k

Countries citing papers authored by Hampton Gillespie

Since Specialization
Citations

This map shows the geographic impact of Hampton Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hampton Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hampton Gillespie more than expected).

Fields of papers citing papers by Hampton Gillespie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hampton Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hampton Gillespie. The network helps show where Hampton Gillespie may publish in the future.

Co-authorship network of co-authors of Hampton Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Hampton Gillespie. A scholar is included among the top collaborators of Hampton Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hampton Gillespie. Hampton Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Volkow, Nora D., et al.. (1996). Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Research Neuroimaging. 67(1). 29–38. 166 indexed citations
2.
Volkow, Nora D., et al.. (1995). Brain glucose metabolism in violent psychiatric patients: a preliminary study. Psychiatry Research Neuroimaging. 61(4). 243–253. 106 indexed citations
3.
Volkow, Nora D., et al.. (1991). Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: A study with positron emission tomography and 18F-2-Fluoro-2-deoxyglucose. Psychiatry Research Neuroimaging. 40(1). 69–78. 69 indexed citations
4.
Johansson, Eva, Hampton Gillespie, & Magnus M. Halldin. (1990). Human Urinary Excretion Profile after Smoking and Oral Administration of [14C]Δ1-Tetrahydrocannabinol*. Journal of Analytical Toxicology. 14(3). 176–180. 13 indexed citations
5.
Hollister, Leo E. & Hampton Gillespie. (1990). The benzodiazepine receptor antagonist, flumazenil does not block clinical effects of delta-9-tetrahydrocannabinol. Life Sciences. 47(18). 1655–1660. 3 indexed citations
6.
Johansson, Eva, et al.. (1987). Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking. Journal of Mass Spectrometry. 14(9). 495–499. 26 indexed citations
7.
Ohlsson, Agneta, et al.. (1986). Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Journal of Mass Spectrometry. 13(2). 77–83. 181 indexed citations
8.
Magliozzi, Joseph R., Hampton Gillespie, Leon Lombrozo, & Leo E. Hollister. (1985). Mood Alteration Following Oral and Intravenous Haloperidol and Relationship to Drug Concentration in Normal Subjects. The Journal of Clinical Pharmacology. 25(4). 285–290. 18 indexed citations
9.
Grant, James D., et al.. (1983). Plasma concentrations of δ-9-tetrahydrocannabinol and impaired motor function. Drug and Alcohol Dependence. 11(2). 167–175. 22 indexed citations
10.
Ohlsson, Agneta, Jan‐Erik Lindgren, A. Wahlén, et al.. (1982). Single dose kinetics of deuterium labelled Δ1-tetrahydrocannabinol in heavy and light cannabis users. Journal of Mass Spectrometry. 9(1). 6–10. 78 indexed citations
11.
Hollister, Leo E., et al.. (1981). Aversive effects of naltrexone in subjects not dependent on opiates. Drug and Alcohol Dependence. 8(1). 37–41. 110 indexed citations
12.
Hollister, Leo E. & Hampton Gillespie. (1975). Interactions in man of delta‐9‐tetrahydrocannabinol; II. Cannabinol and cannabidiol. Clinical Pharmacology & Therapeutics. 18(1). 80–83. 67 indexed citations
13.
Hollister, Leo E. & Hampton Gillespie. (1975). Action of delta‐9‐tetrahydrocannabinol An approach to the active metabolite hypothesis. Clinical Pharmacology & Therapeutics. 18(6). 714–719. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hollister Le Breakdown of academic impact, for papers by J D Sapira Breakdown of academic impact, for papers by Itiro Shirakawa Breakdown of academic impact, for papers by R. T. Jones Breakdown of academic impact, for papers by Monique C. Braude Breakdown of academic impact, for papers by Lineke Zuurman Breakdown of academic impact, for papers by Susan J. Boyd Breakdown of academic impact, for papers by William Notcutt Breakdown of academic impact, for papers by Franziska Pahlisch Breakdown of academic impact, for papers by Heather House
Rankless by CCL
2026